-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Universe Pharmaceuticals INC quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q3 2020 to Q1 2024.
- Universe Pharmaceuticals INC Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending March 31, 2024 was $14.4M, a 17.9% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)